Mabtas 500 Infusion
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Rituximab (500mg)
Overview Mabtas 500 Infusion
Rituximab 500 mg infusion is indicated for various conditions, including non-Hodgkin's lymphoma, rheumatoid arthritis, chronic lymphocytic leukemia, and granulomatosis with polyangiitis/microscopic polyangiitis. Administered intravenously under medical supervision, the dosage and frequency are determined by your physician based on your specific condition and may be adjusted. Strict adherence to the prescribed regimen is crucial; improper use or overdose can lead to severe adverse reactions. Therapeutic effects might not be immediately apparent, requiring weeks or months; discontinue use only as directed by your doctor. Commonly reported side effects include headache, fatigue, swelling, infections, and alopecia. This medication can lower blood cell counts, increasing infection risk, necessitating regular blood tests, including hepatitis B monitoring. Prior to treatment, inform your physician of any pre-existing heart or liver conditions, planned surgeries or immunizations, and all concurrent medications, as drug interactions are possible. Its use is contraindicated during pregnancy and lactation; effective contraception is essential for both partners throughout the treatment period.
Uses of Mabtas 500 Infusion
Chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis, and non-Hodgkin lymphoma.
Major Benefits of Mabtas 500 Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Mabtas 500 Infusion:
- Headache
- Weakness
- Infection
- Chills
- Decreased white blood cell count (neutrophils)
- Fever
- Infusion site reaction
- Lymphopenia
- Abdominal pain
- Back pain
How to use Mabtas 500 Infusion:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Mabtas 500 Infusion works:
Infuximab 500, a monoclonal antibody infusion, neutralizes the aberrant function of B lymphocytes, offering therapeutic benefit in rheumatoid arthritis and selected malignancies.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Mabtas 500 Infusion concurrently with alcohol. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Mabtas 500 Infusion during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Mabtas 500 Infusion without significant risk to their infants. Available human data indicates minimal infant exposure from the drug.
DrivingCONSULT YOUR DOCTOR
The effect of Mabtas 500 Infusion on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
The use of Mabtas 500 Infusion in individuals with kidney impairment appears to pose minimal risk. Preliminary evidence indicates dose modification may be unnecessary. However, physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Mabtas 500 Infusion's use in individuals with hepatic impairment. Physician consultation is advised. Mabtas 500 Infusion is contraindicated for patients experiencing active liver disease or a history of viral hepatitis due to the potential for infection recurrence.
What if you forget to take Mabtas 500 Infusion :
Omit a Mabtas 500 Infusion dose? Seek your physician's advice.
Facts to Know About Mabtas 500 Infusion
| Label | Value |
|---|---|
| Chemical Type | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Category | Anti-CD20 Therapy |
3,018 People bought this recently